)
Denali Therapeutics (DNLI) investor relations material
Denali Therapeutics TD Cowen 46th Annual Health Care Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Strategic overview and 2026 outlook
Anticipates a pivotal year in 2026 with the awaited PDUFA date for tividenofusp alfa for Hunter syndrome on April 5th.
DNL126 for Sanfilippo syndrome is on track for an accelerated approval filing and potential launch in 2027.
Two key clinical data readouts expected: LRRK2 inhibitor in Parkinson’s mid-year and progranulin program in FTD later in the year.
Plans to initiate three new clinical studies, including two Alzheimer’s programs and an enzyme program for Pompe disease.
Well-capitalized with nearly $1 billion in cash and an additional $200 million contingent on approval.
Regulatory and clinical progress
Ongoing, productive FDA dialogue for tividenofusp alfa, with label and post-marketing discussions underway.
Three-month PDUFA delay was due to a corrected molecular weight error, now resolved with no impact on efficacy or safety.
Differentiation from competitors highlighted by robust, long-term data and validated biomarkers.
Strong genetic classification process supports regulatory confidence.
Commercial readiness and launch strategy
Commercial infrastructure and experienced field team in place, with targeted approach due to known patient locations.
Productive payer engagement, with payers recognizing the unmet need and robust data.
Pricing strategy will depend on final label; consensus is growing that all Hunter syndrome patients may benefit.
Adoption expected to start with newborns and severe cases, with an S-shaped adoption curve and revenue inflection in 2027.
Next Denali Therapeutics earnings date
Next Denali Therapeutics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)